![]() |
½ÃÀ庸°í¼
»óÇ°ÄÚµå
1525259
¼¼°èÀÇ ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå ±Ô¸ð Á¶»ç : À¯Çüº°, Áö¿ªº° ¿¹Ãø(2024-2032³â)Global Peripheral Vascular Devices Market Size study, by Type and Regional Forecasts 2024-2032 |
¼¼°è ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀº 2023³â 97¾ï 5,780¸¸ ´Þ·¯·Î Ãß»êµÇ¸ç, 2024³âºÎÅÍ 2032³â±îÁö ¿¬Æò±Õ 6.1% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¸»ÃÊÇ÷°ü ±â±â´Â ½ÉÀå ÀÌ¿ÜÀÇ Ç÷¾×¼øȯ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ¸»ÃÊÇ÷°üÁúȯ(PVD)ÀÇ Ä¡·á¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀº Ç÷°üÀÇ °æ·Ã, ¸·Èû, ÇùÂøÀ» À¯¹ßÇϸç, ƯÈ÷ ´Ù¸®¿Í ³ú¿¡ Ç÷¾×À» °ø±ÞÇÏ´Â Á¤¸Æ°ú ¸²ÇÁ°ü¿¡ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ÀÌ·¯ÇÑ ½Åü ºÎÀ§°¡ È¿°úÀûÀ¸·Î ±â´ÉÇϱâ À§Çؼ´Â ÀûÀýÇÑ Ç÷·ù¿¡ ÀÇÁ¸Çϱ⠶§¹®¿¡ PVD´Â ƯÈ÷ °¡Àå ÀϹÝÀûÀ¸·Î ¿µÇâÀ» ¹Þ±â ½¬¿î ´Ù¸®¿Í Ç㸮ÀÇ °Ç°¿¡ Å« ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.
Àα¸ °í·ÉÈ, ÁÂ½Ä »ýÈ°½À°ü, ´ç´¢º´ ¹× Èí¿¬À² Áõ°¡´Â PVDÀÇ ÁÖ¿ä ÇÏÀ§ ÁýÇÕÀÎ ¸»Ãʵ¿¸ÆÁúȯ(PAD)ÀÇ ¹ß»ý·ü Áõ°¡¿¡ ±â¿©ÇÏ°í ÀÖ½À´Ï´Ù. PAD¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í Áø´Ü ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó Áúº´ÀÇ Á¶±â ¹ß°ßÀÌ Çâ»óµÇ¾î ÀÇ·áÀû °³ÀÔÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó ½ÃÀå ¼ºÀåÀ» °ßÀÎÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀο¡µµ ºÒ±¸ÇÏ°í, ½ÃÀåÀº È¿°úÀûÀÎ ´ëü Ä¡·á¹ý, ƯÈ÷ ³ôÀº È¿´É°ú ³»¾à¼ºÀ¸·Î ÀÎÇØ ³Î¸® »ç¿ëµÇ°í ÀÖ´Â ´Ùºñ°¡Æ®¶õ°ú °°Àº Ç×ÀÀ°íÁ¦ÀÇ µµÀü¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. Ç÷°ü È®ÀåÁ¦, ÄÝ·¹½ºÅ×·Ñ ÀúÇÏÁ¦, Ç×Ç÷¼ÒÆÇÁ¦ µî ´Ù¸¥ ¾à¹°µéµµ PAD Ä¡·áÀÇ ´ë¾ÈÀ¸·Î ÀÛ¿ëÇÏ¿© ¸»ÃÊÇ÷°ü ±â±âÀÇ È®Àå¿¡ Å« Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Á¤ºÎ, ÀÇ·á ±â°ü ¹× ȯÀÚµéÀº ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ°í ȸº¹ ±â°£À» ´ÜÃàÇÏ´Â »õ·Î¿î ±â¼úÀ» äÅÃÇÏ°í ÀÖ¾î ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ°í ÀÖÀ¸¸ç, PAD´Â ³ë³âÃþ¿¡¼ ¸¹ÀÌ ¹ß»ýÇϸç, Àü ¼¼°èÀûÀ¸·Î °í·ÉÈ·Î ÀÎÇØ Ç÷°ü ÁßÀç¼úÀÌ ÇÊ¿äÇÑ È¯ÀÚ ¼ö°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¾î ¸»ÃÊÇ÷°ü ±â±âÀÇ ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ¸»ÃÊÇ÷°ü ±â±â ½ÃÀå Á¶»ç¿¡¼ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, ±âŸ Áö¿ªÀÔ´Ï´Ù. 2023³â ºÏ¹Ì°¡ 39.5%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¸»ÃÊÇ÷°ü ±â±â ½ÃÀåÀ» ÁÖµµÇßÀ¸¸ç, ½ÉÇ÷°ü Áúȯ ¹ßº´·ü Áõ°¡, °í·É Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ½ÃÀåÀ» ÁÖµµÇÏ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¾÷°è ±â¾÷ÀÇ Á¸Àç¿Í Á¦ÈÞ, ÇÕº´, ÆÄÆ®³Ê½Ê, ½ÅÁ¦Ç° Ãâ½Ã¿Í °°Àº Àü·«Àû À̴ϼÅƼºê°¡ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù. À¯·´Àº Àα¸ °í·ÉÈ¿Í Ç÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡, ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇØ ÃÖ¼Òħ½ÀÀû Ç÷°ü ÁßÀç¼ú ÀåºñÀÇ °³¹ßÀ» ÃËÁøÇÏ´Â ÀÇ·á ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀüÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
The global Peripheral Vascular Devices Market was estimated at USD 9,757.8 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.1% from 2024 to 2032. Peripheral vascular devices are critical in the treatment of peripheral vascular diseases (PVDs), which affect blood circulation outside the heart. These conditions can lead to spasms, blockages, or narrowing of the blood vessels, affecting veins and lymphatic vessels, particularly those supplying blood to the legs and brain. As these body parts rely on proper blood flow to function effectively, PVDs can significantly impact health, particularly in the legs and feet, which are most commonly affected.
The aging population, sedentary lifestyles, and the rising prevalence of diabetes and smoking contribute to the growing incidence of Peripheral Artery Disease (PAD), a major subset of PVD. This surge in PAD cases drives the demand for peripheral vascular devices used in both diagnostic and therapeutic interventions. Increased awareness about PAD and advancements in diagnostic techniques have improved early disease detection, thereby increasing the number of patients requiring medical interventions and driving market growth. Despite these growth drivers, the market faces challenges from highly effective alternative treatments, particularly anticoagulant drugs like Dabigatran, which are widely used due to their high efficacy and tolerability. Other medications, such as vasodilators, cholesterol-lowering drugs, and antiplatelet medicines, also serve as alternatives to PAD treatment, posing a significant hurdle to the expansion of peripheral vascular devices. Also, governments, healthcare entities, and patients are increasingly adopting novel technologies that offer enhanced clinical outcomes and quicker recovery periods, further boosting market growth. As PAD is more prevalent among the elderly, the rising aging population globally is expected to increase the number of patients requiring vascular interventions, thereby fostering demand for peripheral vascular devices.
The key regions considered for the Global Peripheral Vascular Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America dominated the peripheral vascular devices market with a revenue share of 39.5%, driven by factors such as the increasing incidence of cardiovascular diseases and a growing geriatric population. The presence of major industry players and their strategic initiatives, including collaborations, mergers, partnerships, and novel product launches, further boost market growth. Europe is anticipated to grow at the fastest CAGR during the forecast period, due to its aging population and rising prevalence of vascular diseases, coupled with continuous advancements in medical technology fostering the development of minimally invasive vascular intervention devices.